PUBLISHER: The Insight Partners | PRODUCT CODE: 1764945
PUBLISHER: The Insight Partners | PRODUCT CODE: 1764945
The Middle East & Africa feed anticoccidials market was valued at US$ 70.20 million in 2023 and is expected to reach US$ 91.26 million by 2031; it is estimated to record a CAGR of 3.3% from 2023 to 2031.
Adoption of Bio Shuttle Program for Managing Coccidiosis Bolsters Middle East & Africa Feed Anticoccidials Market
The bio shuttle program involves strategically using advanced technologies and practices to prevent coccidiosis and enhance bird health and performance. Two main ingredients in a bio shuttle program-vaccines and anticoccidials-are combined to improve poultry health and are essential to the program's continued effectiveness. Birds receive a coccidiosis vaccine at the hatchery; then, an in-feed anticoccidial is administered. Vaccines are all comprised of live Eimeria, which stimulate immunity by providing controlled exposure to coccidia and coccidial cycling. Eimeria, most often associated with Necrotic enteritis (NE), develops deep in the gastrointestinal issue. Thus, in-feed anticoccidials are used in the bio shuttle program after vaccination to lower the peak cycling of the Eimeria.
Producers can improve the general health of their flock by offering complete protection against parasite risks by combining vaccinations with anticoccidials through the bio shuttle program. The program that incorporates in-feed anticoccidials fights against coccidiosis throughout the production cycle and reduces the risk of disease outbreaks. A bio shuttle program can improve feed conversions and weight gain while assisting in managing intestinal injury. Thus, the rising adoption of bio shuttle programs is expected to become a significant trend in the feed anticoccidials market during the forecast period.
Middle East & Africa Feed Anticoccidials Market Overview
Turkey, Kuwait, Qatar, Bahrain, Oman, Egypt, and Kenya are among the major countries in the Rest of the Middle East & Africa feed anticoccidials market. Each country has a unique agricultural landscape and varying levels of poultry farming activity. The demand for feed anticoccidials is driven by the need to ensure the health and performance of the poultry & livestock industry. Anticoccidials play a crucial role in managing coccidiosis diseases that affect animal health. Additionally, the market growth is fueled by several factors, such as government initiatives aimed at improving livestock health and productivity and increasing consumer demand for safe and quality animal products.
Middle East & Africa Feed Anticoccidials Market Revenue and Forecast to 2031 (US$ Million)
Middle East & Africa Feed Anticoccidials Market Segmentation
The Middle East & Africa feed anticoccidials market is segmented based on type, form, livestock, and country. Based on type, the Middle East & Africa feed anticoccidials market is segmented into ionophore, chemical anticoccidials, and chemical-ionophores. The ionophore segment held the largest market share in 2023.
In terms of form, the Middle East & Africa feed anticoccidials market is bifurcated into dry and liquid. The dry segment held a larger market share in 2023.
Based on livestock, the Middle East & Africa feed anticoccidials market is segmented into poultry, ruminants, swine, and others. The poultry segment held the largest market share in 2023.
Based on country, the Middle East & Africa feed anticoccidials market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa feed anticoccidials market share in 2023.
Phibro Animal Health Corp, Zoetis Inc, Kemin Industries Inc, Elanco Animal Health Inc, Huvepharma EOOD, Impextraco NV, and Virbac SA. are some of the leading players operating in the Middle East & Africa feed anticoccidials market.